portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Fosun Pharma acquired Chancheng Hospital
 
CreateTime:2013-10-29     Source:Fosun Pharma Editor:liaoyan
Text Size:       
 

Recently, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, stock code: 600196) acquired Foshan Chancheng Central Hospital Company Ltd (Chancheng Hospital) at RMB693 million. Chancheng Hospital is a private upper first class hospital in Foshan, with registered capital of RMB594.92 million (as of Dec. 31, 2012) and annual revenue of 2012 hitting RMB497.01 million. This acquisition indicated the transformation of Fosun Pharma’s business target in hospital market from upscale market to mass market. 


Related Reports
China Blood Product Industry Report, 2020-2027
China Medical Robot Industry Report, 2020-2026
China In Vitro Diagnostic (IVD) Industry Report, 2019-2025
China Aged Care Industry Report, 2019-2025
China Dental Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1